Low-dose IL-2 as a therapeutic agent for tolerance induction

被引：0
|
作者：
Malek, Thomas R. [1 ,2 ]
Pugliese, Alberto [1 ,2 ,3 ]
机构：
[1] Univ Miami, Miller Sch Med, Dept Microbiol & Immunol, Miami, FL 33101 USA
[2] Univ Miami, Miller Sch Med, Diabet Res Inst, Miami, FL 33101 USA
[3] Univ Miami, Miller Sch Med, Dept Med, Div Endocrinol Diabet & Metab, Miami, FL 33101 USA
来源：
IMMUNOTHERAPY | 2011年 / 3卷 / 11期
关键词：
IL-2; tolerance; T regulatory cells; Type; 1; diabetes; REGULATORY T-CELLS; INTERLEUKIN-2; PRODUCTION; DIABETES-MELLITUS; COMPLEXES; EXPANSION; IMMUNITY;
D O I：
10.2217/IMT.11.120
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：1281 / 1284
页数：4
相关论文
共 50 条
  • [1] Low-dose IL-2 for SLE
    Thorley, Jennifer
    LANCET RHEUMATOLOGY, 2019, 1 (03): : E143 - E143
  • [2] Low-Dose IL-2 in the Treatment of Lupus
    Masayuki Mizui
    George C. Tsokos
    Current Rheumatology Reports, 2016, 18
  • [3] Local low-dose IL-2 therapy
    Den Otter, W
    Balemans, L
    Battermann, JJ
    Bernsen, MR
    Cadee, JA
    Dobrowolski, Z
    Everse, LA
    Fiszer-Maliszewska, L
    Gavhumende, R
    De Groot, JW
    De Groot, K
    Hennink, WE
    Hill, FWG
    Jurgenliemp-Schulz, I
    Klein, WR
    Koten, JW
    Maas, RA
    Steerenberg, P
    Stewart, R
    Zembala, M
    HEPATO-GASTROENTEROLOGY, 1999, 46 : 1280 - 1286
  • [4] Low-Dose IL-2 in the Treatment of Lupus
    Mizui, Masayuki
    Tsokos, George C.
    CURRENT RHEUMATOLOGY REPORTS, 2016, 18 (11)
  • [5] Therapeutic potential of low-dose IL-2 in immune thrombocytopenia: An analysis of 3 cases
    Zhang, Jiakui
    Ruan, Yanjie
    Xu, Xuanxuan
    Wang, Huiping
    Tao, Qianshan
    Lu, Jun
    Xia, Linhuan
    Zhang, Qiuye
    Wang, Jeffrey
    Wang, Yiping
    Zhai, Zhimin
    CYTOMETRY PART B-CLINICAL CYTOMETRY, 2018, 94 (03) : 428 - 433
  • [6] EFFICACY OF LOW-DOSE IL-2 IN PATIENTS WITH MYOSITIS
    Wang, X. M.
    Zhang, J. X.
    Chai, P. H.
    Li, Y. Z.
    Su, Q. Y.
    Yu, Q.
    He, P. F.
    Li, X.
    Zhang, S. X.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 1671 - 1672
  • [7] Low-dose IL-2 therapy for autoimmune diseases
    Collison J.
    Nature Reviews Rheumatology, 2019, 15 (1) : 2 - 2
  • [8] Low-dose IL-2 for patients with systemic lupus erythematosus
    He, Jing
    Sun, Xiaolin
    Li, Zhanguo
    LANCET RHEUMATOLOGY, 2019, 1 (04): : E203 - E203
  • [9] Low-dose IL-2 may enhance the effect of vedolizumab
    Lee, Cheng Hiang
    Huang, Sarah
    Hsu, Peter
    Leong, Rupert
    Nanan, Brigitte
    Nanan, Ralph
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2022, 57 (11) : 1404 - 1405
  • [10] Immunoregulation without immunossupression: the promise of low-dose IL-2
    Klatzmann, D.
    HUMAN GENE THERAPY, 2013, 24 (12) : A17 - A18
12345